Cargando…

Treatment Experiences with CDK4&6 Inhibitors Among Women with Metastatic Breast Cancer: A Qualitative Study

PURPOSE: To describe patients’ perspectives on the use of and potential challenges and barriers with adherence/persistence to cyclin-dependent kinase 4 and 6 inhibitors (CDK4&6i’s) to treat metastatic breast cancer (MBC). METHODS: This qualitative study consisted of 60-minute semi-structured tel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stephenson, Judith J, Gable, Jonathon Colby, Zincavage, Rebekah, Price, Gregory L, Churchill, Collin, Zhu, Emily, Stenger, Keri, Singhal, Mukul, Nepal, Bal, Grabner, Michael, Fisch, Michael J, Debono, David, Geschwender, Amy R, Cuyun Carter, Gebra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8573215/ https://www.ncbi.nlm.nih.gov/pubmed/34764640 http://dx.doi.org/10.2147/PPA.S319239

Ejemplares similares

Data Integration to Improve Real-world Health Outcomes Research for Non–Small Cell Lung Cancer in the United States: Descriptive and Qualitative Exploration
por: Grabner, Michael, et al.
Publicado: (2021)

Prognostic Factors in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative (HR+/HER2–) Advanced Breast Cancer: A Systematic Literature Review
por: Cuyún Carter, Gebra, et al.
Publicado: (2021)

Quality of life analysis of patients treated with cetuximab or cisplatin for locoregionally advanced squamous cell carcinoma of head and neck in the United States
por: Aggarwal, Himani, et al.
Publicado: (2020)

Sustained favorable long-term outcome in the treatment of schizophrenia: a 3-year prospective observational study
por: Cuyún Carter, Gebra B, et al.
Publicado: (2011)

Real-world patient-reported outcomes of women receiving initial endocrine-based therapy for HR+/HER2− advanced breast cancer in five European countries
por: Davie, Alison, et al.
Publicado: (2020)

Adherence and persistence among patients with type 2 diabetes initiating dulaglutide compared with semaglutide and exenatide BCise: 6‐month follow‐up from US real‐world data
por: Mody, Reema, et al.
Publicado: (2020)

A comprehensive review of nongenetic prognostic and predictive factors influencing the heterogeneity of outcomes in advanced non-small-cell lung cancer
por: Cuyún Carter, Gebra, et al.
Publicado: (2014)

Real-World Treatment Sequences and Outcomes Among Patients With Non-Small Cell Lung Cancer (RESOUNDS) in the United States: Study Protocol
por: Hess, Lisa M, et al.
Publicado: (2017)

KRAS testing of patients with metastatic colorectal cancer in a community-based oncology setting: a retrospective database analysis
por: Carter, Gebra Cuyun, et al.
Publicado: (2015)

The Budget Impact of Including Necitumumab on the Formulary for First-Line Treatment of Metastatic Squamous Non-Small Cell Lung Cancer: U.S. Commercial Payer and Medicare Perspectives
por: Bly, Christopher A., et al.
Publicado: (2018)

Occurrence and Characteristics of Hospitalizations During First-Line Chemotherapy Among Individuals with Metastatic Colorectal Cancer
por: Fisch, Michael J, et al.
Publicado: (2020)

Health‐Related Quality of Life in MONARCH 2: Abemaciclib plus Fulvestrant in Hormone Receptor‐Positive, HER2‐Negative Advanced Breast Cancer After Endocrine Therapy
por: Kaufman, Peter A., et al.
Publicado: (2019)

Relative efficacy of interventions in the treatment of second-line non-small cell lung cancer: a systematic review and network meta-analysis
por: Vickers, Adrian D., et al.
Publicado: (2019)

Comprehensive Review on the Clinical Impact of Next-Generation Sequencing Tests for the Management of Advanced Cancer
por: Gibbs, Sarah N., et al.
Publicado: (2023)

Comparative Effectiveness of Persistent Use of a Name-Brand Levothyroxine (Synthroid®) vs. Persistent Use of Generic Levothyroxine on TSH Goal Achievement: A Retrospective Study Among Patients with Hypothyroidism in a Managed Care Setting
por: Wang, Liya, et al.
Publicado: (2021)

Real-World Treatment Patterns among Patients with Advanced Gastric Cancer in South Korea
por: Carter, Gebra Cuyun, et al.
Publicado: (2017)

Immune checkpoint inhibitors: immune-related adverse events, healthcare utilization, and costs among commercial and Medicare Advantage patients
por: Gunturu, Krishna S., et al.
Publicado: (2022)

HSD54 Adherence to Expert Recommendations: Evidence from Oral vs. Infusion Substitution during COVID-19
por: Civelek, Y, et al.
Publicado: (2022)

Activation of cyclin B1–Cdk1 synchronizes events in the nucleus and the cytoplasm at mitosis
por: Gavet, Olivier, et al.
Publicado: (2010)

New-Onset Mania Following Bariatric Surgery
por: Nepal, Hitekshya, et al.
Publicado: (2015)

Real-world clinical profile, treatment patterns and patient-reported outcomes in a subset of HR+/HER2- advanced breast cancer patients with poor prognostic factors: data from an international study
por: Davie, A., et al.
Publicado: (2021)

The SWEET SPOTS study: a real-world interpretation of the 2012 American Diabetes Association Position Statement regarding individualized A1C targets
por: Bieszk, Nella, et al.
Publicado: (2016)

The interplay of CDK4 and CDK6 in melanoma
por: Kollmann, Karoline, et al.
Publicado: (2019)

Association of Patient, Physician, and Practice-Level Factors with Uptake of Payer-Led Oncology Clinical Pathways
por: Mullangi, Samyukta, et al.
Publicado: (2023)

Aplicación de la terapia cognitiva conductual como una alternativa en el tratamiento de personas drogodependientes de la ciudad de Guatemala/
por: Solórzano Cuyún, María Antonieta
Publicado: (2011)

Cyclin K goes with Cdk12 and Cdk13
por: Kohoutek, Jiri, et al.
Publicado: (2012)

CDK2 Regulates HIV-1 Transcription by Phosphorylation of CDK9 on Serine 90
por: Breuer, Denitra, et al.
Publicado: (2012)

Coping Work Strategies and Job Satisfaction Among Iranian Nurses
por: Ghiyasvandian, Shahrzad, et al.
Publicado: (2014)

The yeast protein kinase Mps1p is required for assembly of the integral spindle pole body component Spc42p
por: Castillo, Andrea R., et al.
Publicado: (2002)

CDK3, CDK5 and CDK8 Proteins as Prognostic and Potential Biomarkers in Colorectal Cancer Patients
por: Wang, Dan, et al.
Publicado: (2022)

Real-world survival outcomes of heavily pretreated patients with refractory HR+, HER2−metastatic breast cancer receiving single-agent chemotherapy—a comparison with MONARCH 1
por: Rugo, Hope S., et al.
Publicado: (2020)

Exploratory analysis of front-line therapies in REVEL: a randomised phase 3 study of ramucirumab plus docetaxel versus docetaxel for the treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy
por: Garon, Edward B, et al.
Publicado: (2020)

An open label, randomized phase 2 trial assessing the impact of food on the tolerability of abemaciclib in patients with advanced breast cancer
por: Lim, Elgene, et al.
Publicado: (2022)

The CDK-activating kinase Cdk7: Taking yes for an answer
por: Schachter, Miriam Merzel, et al.
Publicado: (2013)

Regulatory functions of the Mediator kinases CDK8 and CDK19
por: Fant, Charli B., et al.
Publicado: (2018)

KNIME-CDK: Workflow-driven cheminformatics
por: Beisken, Stephan, et al.
Publicado: (2013)

Multiple CDK inhibitor dinaciclib suppresses neuroblastoma growth via inhibiting CDK2 and CDK9 activity
por: Chen, Zhenghu, et al.
Publicado: (2016)

Inducible deletion of CDK4 and CDK6 – deciphering CDK4/6 inhibitor effects in the hematopoietic system
por: Maurer, Barbara, et al.
Publicado: (2020)

Advance Care Planning Claims and Health Care Utilization Among Seriously Ill Patients Near the End of Life
por: Ashana, Deepshikha Charan, et al.
Publicado: (2019)

Regulation of CDK9 Activity by Phosphorylation and Dephosphorylation
por: Nekhai, Sergei, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_lu5eg63sf8v0j31n2s5csj8ui8